# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-014002
Filing Date
2021-04-23
Accepted
2021-04-23 06:10:20
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | nc10023262x2_defa14a.htm | DEFA14A | 23684
2 |  | nc10023262x2_pc01.jpg | GRAPHIC | 400942
3 |  | nc10023262x2_pc02.jpg | GRAPHIC | 274040
| Complete submission text file | 0001140361-21-014002.txt |  | 954689

Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19125 | Film No.: 21846616
SIC: 2834 Pharmaceutical Preparations